| Dr Deborah Jean Accetta Pedersen, MD | |
|
101 Industrial Park Rd, Suite 307, Taunton, MA 02780-7393 | |
| (508) 880-3121 | |
| (508) 880-0926 |
| Full Name | Dr Deborah Jean Accetta Pedersen |
|---|---|
| Gender | Female |
| Speciality | Allergy/immunology |
| Experience | 19 Years |
| Location | 101 Industrial Park Rd, Taunton, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023281532 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 246209 (Massachusetts) | Primary |
| 208000000X | Pediatrics | 125049414 (Illinois) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Signature Healthcare Brockton Hospital | Brockton, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allergy And Asthma Care Pc | 9537233838 | 3 |
News Archive
Versions of an antibiotic drug called DON first isolated from soil bacteria more than 60 years ago have shown promising signs of extending survival in mice models of especially lethal pediatric brain tumors marked by the high expression of a cancer-causing gene known as the MYC oncogene, according to results of two studies from researchers at the Johns Hopkins Kimmel Cancer Center.
Giving the drug metformin to women diagnosed with preterm pre-eclampsia may help to prolong pregnancy (gestation), finds a study published by The BMJ today.
In a recent survey of palliative care medicine practitioners, nearly three quarters of the sample reported having been "humorously" accused of promoting death; for example, being called "Dr. Death." Most of the remarks came from fellow physicians and other health care professionals. At the same time, the survey found that a third of investigations into accusations of murder or euthanasia against physicians are instigated by fellow members of the health care team.
Only a few anti-spasticity medications used for children with cerebral palsy are backed by sufficient research to justify their use, according to a new review of scientific literature headed by a UT Southwestern Medical Center neurologist and conducted by a national panel of interdisciplinary experts nationwide.
Zenobia Therapeutics, Inc. the leader in fragment-based lead discovery for CNS diseases, announced today a research collaboration with H. Lundbeck A/S utilizing Zenobia's expertise in protein expression and x-ray crystallography for the Parkinson's disease target, LRRK2. Under the agreement, Zenobia will continue to use its capabilities in fragment-based lead discovery (FBLD) to advance its internal LRRK2 drug discovery program independently of Lundbeck.
› Verified 8 days ago
| Entity Name | Allergy & Asthma Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942370010 PECOS PAC ID: 9537233838 Enrollment ID: O20080805000411 |
News Archive
Versions of an antibiotic drug called DON first isolated from soil bacteria more than 60 years ago have shown promising signs of extending survival in mice models of especially lethal pediatric brain tumors marked by the high expression of a cancer-causing gene known as the MYC oncogene, according to results of two studies from researchers at the Johns Hopkins Kimmel Cancer Center.
Giving the drug metformin to women diagnosed with preterm pre-eclampsia may help to prolong pregnancy (gestation), finds a study published by The BMJ today.
In a recent survey of palliative care medicine practitioners, nearly three quarters of the sample reported having been "humorously" accused of promoting death; for example, being called "Dr. Death." Most of the remarks came from fellow physicians and other health care professionals. At the same time, the survey found that a third of investigations into accusations of murder or euthanasia against physicians are instigated by fellow members of the health care team.
Only a few anti-spasticity medications used for children with cerebral palsy are backed by sufficient research to justify their use, according to a new review of scientific literature headed by a UT Southwestern Medical Center neurologist and conducted by a national panel of interdisciplinary experts nationwide.
Zenobia Therapeutics, Inc. the leader in fragment-based lead discovery for CNS diseases, announced today a research collaboration with H. Lundbeck A/S utilizing Zenobia's expertise in protein expression and x-ray crystallography for the Parkinson's disease target, LRRK2. Under the agreement, Zenobia will continue to use its capabilities in fragment-based lead discovery (FBLD) to advance its internal LRRK2 drug discovery program independently of Lundbeck.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Deborah Jean Accetta Pedersen, MD 101 Industrial Park Rd, Suite 307, Taunton, MA 02780-7393 Ph: (508) 880-3121 | Dr Deborah Jean Accetta Pedersen, MD 101 Industrial Park Rd, Suite 307, Taunton, MA 02780-7393 Ph: (508) 880-3121 |
News Archive
Versions of an antibiotic drug called DON first isolated from soil bacteria more than 60 years ago have shown promising signs of extending survival in mice models of especially lethal pediatric brain tumors marked by the high expression of a cancer-causing gene known as the MYC oncogene, according to results of two studies from researchers at the Johns Hopkins Kimmel Cancer Center.
Giving the drug metformin to women diagnosed with preterm pre-eclampsia may help to prolong pregnancy (gestation), finds a study published by The BMJ today.
In a recent survey of palliative care medicine practitioners, nearly three quarters of the sample reported having been "humorously" accused of promoting death; for example, being called "Dr. Death." Most of the remarks came from fellow physicians and other health care professionals. At the same time, the survey found that a third of investigations into accusations of murder or euthanasia against physicians are instigated by fellow members of the health care team.
Only a few anti-spasticity medications used for children with cerebral palsy are backed by sufficient research to justify their use, according to a new review of scientific literature headed by a UT Southwestern Medical Center neurologist and conducted by a national panel of interdisciplinary experts nationwide.
Zenobia Therapeutics, Inc. the leader in fragment-based lead discovery for CNS diseases, announced today a research collaboration with H. Lundbeck A/S utilizing Zenobia's expertise in protein expression and x-ray crystallography for the Parkinson's disease target, LRRK2. Under the agreement, Zenobia will continue to use its capabilities in fragment-based lead discovery (FBLD) to advance its internal LRRK2 drug discovery program independently of Lundbeck.
› Verified 8 days ago
Dr. Donald D Accetta, M.D., M.P.H Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 101 Industrial Park Road, Suite 307, Taunton, MA 02780 Phone: 508-880-3121 Fax: 808-880-0926 | |
Hormoz Solomon, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 101 Industrial Park Rd Ste 700, Taunton, MA 02780 Phone: 508-880-3121 Fax: 088-800-9265 |